Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phase Ib/II study of BEZ-235 launched

Oct. 31, 2011

Acceleron Pharma begins phase II trial of ACE-041 in head and neck cancer

Oct. 31, 2011

Eviendep may alter neoproliferative processes in intestinal mucosa

Oct. 31, 2011

European Commission extends Alimta approval

Oct. 28, 2011

Researchers at Abbott claim novel inhibitors of Bcl-2

Oct. 28, 2011

Marina Biotech presents novel nucleic acid complexes

Oct. 28, 2011

TopoTarget patents new nicotinamide phosphoribosyltransferase inhibitors

Oct. 28, 2011

New Wnt signaling inhibitors discovered in Germany

Oct. 28, 2011

Adventrx and FDA agree on pivotal ANX-514 trial

Oct. 28, 2011

S*BIO plans phase III program for pacritinib

Oct. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...